Newsroom

HAMILTON, Bermudas--(BUSINESS WIRE)--A Bacardi Limited anunciou a conclusão de uma transação que torna a empresa familiar a única proprietária da Teeling Whiskey Company e da marca de whisky irlandês TEELING®. Os fundadores Jack e Stephen Teeling continuarão fazendo parte da marca, moldando seu futuro e impulsionando o crescimento a longo prazo como consultores estratégicos. O anúncio de hoje surge na sequência da bem-sucedida relação entre as duas empresas desde que a Bacardi adquiriu uma part...

MILWAUKEE--(BUSINESS WIRE)--Zurn Elkay Water Solutions Corporation (NYSE: ZWS) has been named one of America’s High-Growth Companies 2026 for the first time by Business Insider and Plant-A Insights Group. Among the 500 companies on the list, Zurn Elkay is one of only 50 manufacturers and one of only six Wisconsin-based companies. “With clean, safe water at the heart of our business, our growth strategy and our sustainability strategy are increasingly the same,” said Todd A. Adams, Chairman and...

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” (Excellent) of Allshores General Insurance Company (Bermuda) Limited, Allshores Life and Benefits Company (Bermuda) Limited and Island Heritage Insurance Company, Ltd. (Cayman Islands). Concurrently, AM Best has affirmed the Long-Term ICR of “bbb” (Good) of the parent company, Allshores Limited (Allshores). The outlook of these Credit...

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to ten classes of mortgage-backed certificates from Angel Oak Mortgage Trust 2026-3 (AOMT 2026-3), a $279.6 million non-prime RMBS transaction. The underlying collateral, comprised of 589 residential mortgages, is characterized by a significant concentration of loans underwritten using alternative income documentation. All the loans are either classified as non-qualified mortgages (Non-QM) (43.8%) or exempt (56.2%) from the Ability-to-...

AU, Suiza y PRINCETON, Nueva Jersey--(BUSINESS WIRE)--Araris Biotech AG, una empresa que desarrolla una cartera diferenciada de terapias basadas en conjugados anticuerpo-fármaco (ADC), y Taiho Oncology, Inc., dedicada al desarrollo y la comercialización de tratamientos innovadores para neoplasias hematológicas y tumores sólidos, ambas pertenecientes al grupo Taiho, han anunciado hoy la dosificación del primer paciente en un ensayo clínico de fase 1 de ARC-02, un conjugado anticuerpo-fármaco dir...

AU, Svizzera e PRINCETON, N.J.--(BUSINESS WIRE)--Araris Biotech AG, azienda che promuove una pipeline diversificata di terapie a base di farmaci anticorpo-coniugati (“ADC”), e Taiho Oncology, Inc., società specializzata nello sviluppo e nella commercializzazione di nuovi trattamenti per neoplasie ematologiche maligne e tumori solidi, entrambi membri del gruppo Taiho, oggi hanno annunciato che il primo paziente ha ricevuto il trattamento in uno studio clinico di fase 1 su ARC-02, un farmaco anti...

WEST HOLLYWOOD, Calif.--(BUSINESS WIRE)--Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced that its Board of Directors has appointed George Arison, the company's Chief Executive Officer, to the additional role of Chairman of the Board, effective June 23. J. Michael Gearon, Jr., will continue to serve as Lead Independent Director. The appointment comes at a time of growing momentum for Grindr. Since Arison joined the Company, it has delivered outstanding financial...

MIAMI LAKES, Fla.--(BUSINESS WIRE)--BankUnited, Inc. (NYSE: BKU) financial results for the quarter ended June 30, 2026 will be made public on Wednesday, July 22, 2026....

DALLAS---(BUSINESS WIRE)--HF Sinclair Corporation (NYSE and NYSE Texas: DINO) (“HF Sinclair”) plans to announce results for the quarter ending June 30, 2026, on July 28, 2026, before the opening of trading on the NYSE and NYSE Texas. HF Sinclair has scheduled a webcast conference on July 28, 2026, at 8:30 a.m. Eastern time to discuss financial results. This webcast may be accessed at: https://events.q4inc.com/attendee/654044265 An audio archive of this webcast will be available using the above...

AU, Suisse et PRINCETON, New Jersey--(BUSINESS WIRE)--Araris Biotech AG, société développant un portefeuille différencié de thérapies par conjugués anticorps-médicament (« ADC »), et Taiho Oncology, Inc., société développant et commercialisant de nouveaux traitements pour les hémopathies malignes et les tumeurs solides, toutes deux membres du groupe Taiho, ont annoncé aujourd'hui que, dans le cadre d'un essai clinique de phase 1, le premier patient avait reçu une dose d'ARC-02, un conjugué anti...